Sharing this one because it's exactly the kind of "knowledge is armor" story that matters most to this community. Yale researchers published findings this week on PSMA-PET imaging — a newer technology for detecting prostate cancer spread. Compared to traditional bone scans, PSMA-PET detects spread earlier and with greater sensitivity. Men who received this imaging were more likely to start the right treatment sooner. It's not experimental. It's available at major cancer centres now. The issue is that most men and families don't know to ask for it specifically. The pattern I keep coming back to: the advances happen, the evidence accumulates, and then they sit behind clinical inertia while men receive the older, less sensitive approach — not because PSMA-PET isn't available, but because nobody told them it was an option. The question to ask if you or someone you love is at the staging or restaging point: "Is PSMA-PET imaging available here, and is it appropriate for my situation?" Has anyone in the community had experience with PSMA-PET imaging? Did it change your treatment decisions?

Something from this week's news cycle that I think is worth talking about here. Health experts published concerns this week about the number of men showing up to clinics with advanced BPH that has been silently worsening for years. The common thread: men assumed the symptoms were just ageing, so they never mentioned them. This isn't a single country's story. It's a universal one. The progression of BPH is quiet and gradual. The night trips, the weak stream, the urgency — they feel like background noise. So men file it under "normal" and keep going. By the time they mention it, the options have narrowed. What this community exists to do — and what both my books are built around — is change that default. From "I'll deal with it" to "I'll mention it." From silent worsening to informed conversation. Has anyone here had the experience of mentioning a symptom earlier than you expected and being glad you did? What made you finally say something?

Sharing this here first because I know some of you are in this territory or supporting people who are. Mayo Clinic published a guide this week on advanced prostate cancer — what it means when cancer has spread, what treatment options look like, and what the road ahead involves. Written for patients and families. Plain language, honest, practical. I've spent sixteen years researching prostate health, and I wrote about navigating advanced diagnoses in Prostate Mania precisely because this kind of accessible information is so hard to find in the moments it's most needed. "Advanced" doesn't mean what it meant ten years ago. Treatment has changed. Survival rates have changed. A lot of the fear around an advanced diagnosis is based on an outdated picture — and good plain-language information is one of the most powerful things you can put in someone's hands. If anyone in the community has recently navigated this — personally or supporting a family member — how did you find the information you needed? What helped, and what was missing?https://mcpress.mayoclinic.org/advanced-prostate-cancer/the-mayo-clinic-way-of-advanced-prostate-cancer-treatment/

Sharing this with the community because it speaks to something I've thought about for years. Emory's Winship Cancer Institute is running a mobile prostate cancer screening programme in Georgia — driving a bus to public libraries and offering free PSA blood tests for men 40–75. No appointment, no physical exam, no bill. They recently passed 1,000 patients screened. The design principle is simple: Black men and men without easy access to healthcare are the most underserved by traditional prostate cancer screening pathways. So Winship went to where those men already are — libraries, community spaces, places that already belong to the community. It's the kind of programme that shouldn't feel novel in 2026. But it does. I want to open this up here: what are people in this community seeing in terms of access to prostate screening? Whether you're in the UK, the US, Australia, or elsewhere — how hard is it actually for the men in your life to get a PSA test? And when they don't get one, what's the barrier?

Unfold AI — a platform that uses artificial intelligence to map prostate cancer within the prostate gland — has been added to Medicare's Physician Fee Schedule. That means it's now reimbursable for Medicare patients across the US, removing a significant access barrier. The clinical value is real: standard biopsy mapping gives doctors a limited picture of where cancer sits within the gland. AI-assisted mapping provides significantly more detail — which zone, how close to key structures, how much of the gland is involved. That information directly shapes treatment decisions. For men navigating a prostate cancer diagnosis, this matters in two ways: practically, if you're Medicare-eligible, this tool may now be available to you and it's worth asking about. And symbolically — it represents AI becoming a routine part of prostate cancer care, not an experimental extra. What's the community's experience with this? Has anyone here encountered AI-assisted prostate mapping in a clinical setting — as a patient, a caregiver, or a healthcare professional? And for those who haven't: is this the kind of information you'd want to know about when navigating a diagnosis?